Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The effects of 2 weeks of statin treatment on mitochondrial respiratory capacity in middle-aged males: the LIFESTAT study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Drug-drug interactions between vitamin K antagonists and statins: a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  2. The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Use of prescription drugs in the older adult population-a nationwide pharmacoepidemiological study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effects of endogenous GIP in patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The training induced increase in whole-body peak fat oxidation rate may be attenuated with aging

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mitochondrial dysfunction in adults after out-of-hospital cardiac arrest

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Statins are used to lower cholesterol in plasma and are one of the most used drugs in the world. Many statin users experience muscle pain, but the mechanisms are unknown at the moment. Many studies have hypothesized that mitochondrial function could be involved in these side effects.

AIM: The aim of the study was to investigate mitochondrial function after 2 weeks of treatment with simvastatin (S; n = 10) or pravastatin (P; n = 10) in healthy middle-aged participants.

METHODS: Mitochondrial respiratory capacity and substrate sensitivity were measured in permeabilized muscle fibers by high-resolution respirometry. Mitochondrial content (citrate synthase (CS) activity), antioxidant content, as well as coenzyme Q10 concentration (Q10) were determined. Fasting plasma glucose and insulin concentrations were measured, and whole body maximal oxygen uptake (VO2max) was determined.

RESULTS: No differences were seen in mitochondrial respiratory capacity although a tendency was observed for a reduction when complex IV respiration was analyzed in both S (229 (169; 289 (95% confidence interval)) vs. 179 (146; 211) pmol/s/mg, respectively; P = 0.062) and P (214 (143; 285) vs. 162 (104; 220) pmol/s/mg, respectively; P = 0.053) after treatment. A tendency (1.64 (1.28; 2.00) vs. 1.28 (0.99; 1.58) mM, respectively; P = 0.092) for an increased mitochondrial substrate sensitivity (complex I-linked substrate; glutamate) was seen only in S after treatment. No differences were seen in Q10, CS activity, or antioxidant content after treatment. Fasting glucose and insulin as well as VO2max were not changed after treatment.

CONCLUSION: Two weeks of statin (S or P) treatment have no major effect on mitochondrial function. The tendency for an increased mitochondrial substrate sensitivity after simvastatin treatment could be an early indication of the negative effects linked to statin treatment.

Original languageEnglish
JournalEuropean Journal of Clinical Pharmacology
Volume73
Issue number6
Pages (from-to)679-687
Number of pages9
ISSN0031-6970
DOIs
Publication statusPublished - Jun 2017

    Research areas

  • Journal Article

ID: 51613232